Seoul Economic TV
InDream Healthcare CEO presents CARES reanalysis at the European rheumatology congress
Article summary
CEO Byeongzu Ghang presented a reanalysis of the CARES study in patients with gout at the European rheumatology congress.
The presentation examined the relationship between uric acid levels and cardiovascular event risk during long-term urate-lowering treatment, discussing sustained uric acid management from a research perspective.
Source: Seoul Economic TV
This is a summary of the article at publication. Select “View original” to read it within this page.
External originals are displayed in the language provided by their publisher.
